HINJ’s Chrissy Buteas Named to NJII Board of Directors
Buteas, Charters named to board of NJII (BINJE.com) August 5 ― Chrissy Buteas and Elisa Charters have been named to the Board of Directors of the New Jersey Innovation Institute, the organization announced. NJII, a subsidiary of the New Jersey Institute of Technology, is uniquely positioned to be agile, entrepreneurial, and opportunistic. NJII focuses on accelerating technology […]
Knowledge and Networking: This is How Innovation Happens (BINJE.com)
July 29, 2025 ―More than 75 leaders in higher education, technology and life sciences, local and county government and economic development gathered in a conference room at the New Brunswick Performing Arts Center Tuesday morning to hear presentations on the innovative research that will take place at the HELIX, the workforce development being created at […]
HealthCare Institute of New Jersey Reacts to FDA’s Commissioner’s Voucher Program
June 17, 2025 ― On June 17, the Food and Drug Administration announced a new national priority voucher plan whose aim is to reduce drug review times to one to two months from the current average of 10 to 12 months. Chrissy Buteas, president and chief executive officer of the HealthCare Institute of New Jersey, in a […]
HealthCare Institute of New Jersey Statement on FDA’s Commissioner’s National Priority Voucher (CNPV) Program
Trenton, June 19, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning this week’s announcement of the Food and Drug Administration (FDA)’s Commissioner’s National Priority Voucher (CNPV) program for accelerating FDA approvals: “Researching and discovering a new treatment or cure can take a […]
HealthCare Institute of New Jersey Statement on CDC Vaccine Advisory Panel
Trenton, June 10, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning yesterday’s announcement of the Centers for Disease Control and Prevention’s (CDC) reconstitution of the Advisory Committee for Immunization Practices (ACIP): “Vaccines remain one of humanity’s most critical defenses against deadly viral […]
HINJ Article: Artificial Intelligence is Accelerating the Life Sciences’ Quest for New Treatments and Cures
Two articles by HINJ featured in New Jersey Business Magazine’s June Innovation Edition. New Jersey positioned to be a global leader as artificial intelligence revolutionizes medical innovation by HINJ CEO Chrissy Buteas Saving lives globally while finding cures in New Jersey by HINJ CEO Chrissy Buteas The full June edition (“34th Annual Innovative State”) can […]
Op-Ed: New Jersey’s Life Sciences: Keeping the World Healthy for 150 Years
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) May 28, 2025 – As America prepares to celebrate our 250th anniversary, it’s worth reminding ourselves that New Jersey has been known as the “Crossroads of the Revolution” since our nation’s founding. From Washington’s daring Delaware River crossing to surprise British and […]
HealthCare Institute of New Jersey Statement on Make America Healthy Again Report
Trenton, May 22, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning today’s release of the Make America Healthy Again report: “The sole mission of New Jersey’s life sciences is to help American patients and those around the world live longer, with greater […]
Op-Ed: ‘Most Favored Nation’ Proposal Won’t Favor American Patients or New Jersey Jobs
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) A new threat has suddenly emerged for American patients and New Jersey’s economy. A proposal called “Most Favored Nation” (MFN) is being discussed by some policymakers in Washington. While the intended goal is admirable – to lower healthcare costs – the actual […]
HealthCare Institute of New Jersey Statement on White House “Most Favored Nation” Executive Order
Trenton, May 12, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s White House Executive Order on the “Most Favored Nation” drug pricing action: “This ‘most favored nation’ (MFN) proposal won’t favor American patients or New Jersey jobs. This idea takes parts […]